Metsera, Inc.

Railpen lifts IP Group offer with cash, Nanopore stake and Metsera upside

IP Group shares jump 9% as Metsera deal drives return to growth

Metsera Inc. (NASDAQ:MTSR) Given Average Recommendation of “Hold” by Brokerages

Pfizer Completes Acquisition of Metsera

Metsera shareholders vote for $10 billion acquisition by Pfizer

Why Metsera's Share Price Is Plummeting This Week

Instacart Up on Earnings Beat; Metsera Down on Takeover Battle | Stock Movers

Pfizer to acquire Metsera after winning bidding contest against Novo Nordisk

Pfizer to buy Metsera in deal worth up to $10 billion

Pfizer CEO: Metsera deal gives us 'one of the most exciting, advanced portfolios' in obesity drugs

5 Things to Know Before the Stock Market Opens

Pfizer Is Buying Weight-Loss Drugmaker Metsera. Why Novo Nordisk Is the Winner.

Monday.Com, Metsera, Profrac Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Novo Nordisk Shares Rise After Withdrawal from Metsera Takeover Battle

Novo Nordisk shares rise after dropping Metsera bid

Wall Street Brunch: Here Come The 13Fs

Novo Nordisk will not increase its proposal to acquire Metsera, Inc.

Pfizer has agreed to buy weight-loss drug startup Metsera in a deal that could be worth more than $10 billion, besting rival Novo Nordisk following a heated bidding war

Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer

Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports